These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 973959)

  • 41. A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.
    Aellig WH; Narjes HH; Nüesch E; Oertle RJ; Devos JE; Pacha W
    Eur J Clin Pharmacol; 1981; 20(3):179-83. PubMed ID: 7286035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A class experiment in clinical pharmacology using beta-adrenoceptor antagonist drugs.
    Kumana CR; Ogle CW
    Br J Clin Pharmacol; 1985 Feb; 19(2):169-75. PubMed ID: 2859042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
    Buckingham RE; Hamilton TC; Robson D
    Br J Pharmacol; 1977 Jul; 60(3):461-9. PubMed ID: 19118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Action of isoprenaline and -blocking agents on stroke volume regulation.
    Fenyvesi T; Hadházy P
    Eur J Pharmacol; 1973 Apr; 22(1):105-8. PubMed ID: 4145253
    [No Abstract]   [Full Text] [Related]  

  • 45. Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.
    Jennings GL; Bobik A; Fagan ET; Korner PI
    Br J Clin Pharmacol; 1979 Mar; 7(3):245-56. PubMed ID: 427002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Observations on three dosage forms of pindolol.
    Carruthers SG
    Am Heart J; 1982 Aug; 104(2 Pt 2):451-5. PubMed ID: 7102531
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol].
    Gries J; Unger L; Einig H; Friedrich L; Hofmann HP; Kreiskott H; Lehmann HD; von Philipsborn G; Wuppermann D; Zimmermann F
    Arzneimittelforschung; 1988 Sep; 38(9):1271-9. PubMed ID: 2906243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-adrenoceptor blocking drugs at maximum beta-blockade in relation to dose and plasma concentration.
    Gugler R; Krist R; Raczinski H; Höffgen K; Boden G
    Cardiology; 1979; 64 Suppl 1():20-4. PubMed ID: 42486
    [No Abstract]   [Full Text] [Related]  

  • 50. Investigations with beta-adrenoceptor blocking drugs in healthy volunteers.
    Aellig WH
    Acta Med Scand Suppl; 1977; 606():71-5. PubMed ID: 19932
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.
    Cuthbert MF; Owusu-Ankomah K
    Br J Pharmacol; 1971 Nov; 43(3):639-48. PubMed ID: 4400530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beta-blocking potency of mepindolol and pindolol against isoproterenol-induced inotropic and chronotropic responses in guinea pig atria.
    Anderson WG
    J Cardiovasc Pharmacol; 1984; 6(1):7-11. PubMed ID: 6199615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison between the influence of pindolol and propranolol on the response of plasma potassium to catecholamines.
    Castro-Tavares J
    Arzneimittelforschung; 1976 Feb; 26(2):238-41. PubMed ID: 947205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative studies of antihypertensive effects of several beta-blocking agents in conscious rats (author's transl)].
    Ozawa H; Watanabe H; Chen CS
    Nihon Yakurigaku Zasshi; 1978 Jan; 74(1):139-44. PubMed ID: 25230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contrasts between pindolol and propranolol concentration-response relationships.
    Carruthers SG; Pacha WL; Aellig WH
    Br J Clin Pharmacol; 1985 Oct; 20(4):417-20. PubMed ID: 4074610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of propranolol on exercise induced tachycardia is determined by plasma concentration and the density of adrenergic receptors on leukocytes.
    Tawara K; Steiner E; von Bahr C
    Eur J Clin Pharmacol; 1987; 31(6):667-72. PubMed ID: 3830254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study on the cardiodepressant action of a beta-blocking agent carteolol in heart-lung preparation of the dog.
    Ono H; O'Hara N
    Jpn Circ J; 1984 Sep; 48(9):1030-44. PubMed ID: 6481940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
    Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T
    Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.